Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
NRDBY Quote, Financials, Valuation and Earnings
Last price:
$10.66
Seasonality move
:
5.05%
Day range:
$10.56 - $10.76
52-week range:
$10.56 - $12.90
Dividend yield:
9.31%
P/E ratio:
6.92x
P/S ratio:
2.88x
P/B ratio:
1.06x
Volume:
554.9K
Avg. volume:
297.5K
1-year change:
-11.54%
Market cap:
$37.3B
Revenue:
$12.7B
EPS (TTM):
$1.54
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $9.4B | $9.7B | $11.4B | $10.2B | $12.7B | |
| Revenue Growth (YoY) | -7.56% | 2.68% | 17.8% | -10.68% | 24.51% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.7B | $1.3B | $1.1B | $1.1B | $1.2B | |
| Other Inc / (Exp) | $1.1B | $991.3M | $1.3B | $657M | $1.1B | |
| Operating Expenses | $5.6B | $5.2B | $5.4B | $5.1B | $5.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.4B | $3.4B | $5.8B | $5B | $6.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $639.2M | $797.1M | $1.3B | $1.2B | $1.5B | |
| Net Income to Company | $2.4B | $3.4B | $5.8B | $5B | $6.9B | |
| Minority Interest in Earnings | $3.4M | -- | -- | $2.1M | -- | |
| Net Income to Common Excl Extra Items | $1.7B | $2.6B | $4.5B | $3.8B | $5.3B | |
| Basic EPS (Cont. Ops) | $0.43 | $0.63 | $1.12 | $0.99 | $1.48 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.63 | $1.12 | $0.99 | $1.48 | |
| Weighted Average Basic Share | $4B | $4B | $4B | $3.8B | $3.6B | |
| Weighted Average Diluted Share | $4B | $4B | $4B | $3.8B | $3.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.9B | $5.2B | $6.7B | $8.3B | $20.2B | |
| Revenue (Reported) | $9.4B | $9.7B | $11.4B | $10.2B | $12.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.9B | $5.2B | $6.7B | $8.3B | $20.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.8B | $2.5B | $3.2B | $3.3B | |
| Revenue Growth (YoY) | 9.94% | 9.9% | -11.49% | 30.26% | 3.17% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $245.6M | $252.3M | $252.9M | $284.2M | $354.1M | |
| Other Inc / (Exp) | $277.1M | $240.5M | $250.8M | $247.2M | $291.4M | |
| Operating Expenses | $1.3B | $1.3B | $1.1B | $1.3B | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | $1.5B | $1.3B | $1.9B | $1.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $290M | $314.8M | $285.1M | $413.7M | $404.7M | |
| Net Income to Company | $1.3B | $1.4B | $1.2B | $1.9B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $978.8M | $1.2B | $1B | $1.5B | $1.4B | |
| Basic EPS (Cont. Ops) | $0.25 | $0.29 | $0.27 | $0.41 | $0.40 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.29 | $0.27 | $0.41 | $0.40 | |
| Weighted Average Basic Share | $4B | $4B | $3.7B | $3.5B | $3.5B | |
| Weighted Average Diluted Share | $4B | $4B | $3.7B | $3.6B | $3.5B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.7B | $1.7B | $2.2B | $5.6B | $5.5B | |
| Revenue (Reported) | $2.5B | $2.8B | $2.5B | $3.2B | $3.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.7B | $1.7B | $2.2B | $5.6B | $5.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.4B | $11.3B | $10.1B | $12.5B | $13.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.3B | $1.2B | $1B | $1.2B | $1.4B | |
| Other Inc / (Exp) | $955M | $1.2B | $513M | $1.3B | $1B | |
| Operating Expenses | $4B | $5.6B | $5.1B | $5.4B | $5.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $3.4B | $5.5B | $4.8B | $7B | $7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $804M | $1.3B | $1.2B | $1.5B | $1.6B | |
| Net Income to Company | $3.5B | $5.4B | $4.7B | $7.2B | $7.1B | |
| Minority Interest in Earnings | $3.3M | -- | $2.2M | -- | -- | |
| Net Income to Common Excl Extra Items | $2.6B | $4.2B | $3.6B | $5.5B | $5.5B | |
| Basic EPS (Cont. Ops) | $0.64 | $1.04 | $0.93 | $1.51 | $1.54 | |
| Diluted EPS (Cont. Ops) | $0.64 | $1.04 | $0.93 | $1.51 | $1.54 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $5.9B | $6.5B | $6.4B | $18.4B | $22.2B | |
| Revenue (Reported) | $9.4B | $11.3B | $10.1B | $12.5B | $13.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $5.9B | $6.5B | $6.4B | $18.4B | $22.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $7.1B | $8.7B | $7.2B | $9.6B | $9.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $974.4M | $819.9M | $779.3M | $869.8M | $1.1B | |
| Other Inc / (Exp) | $694.7M | $957.6M | $258M | $914.6M | $865.9M | |
| Operating Expenses | $3.8B | $4.2B | $3.9B | $4.1B | $4.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.3B | $4.4B | $3.3B | $5.3B | $5.5B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $512.8M | $1B | $872.4M | $1.2B | $1.3B | |
| Net Income to Company | $2.3B | $4.3B | $3.2B | $5.4B | $5.6B | |
| Minority Interest in Earnings | -- | -- | $2.2M | -- | -- | |
| Net Income to Common Excl Extra Items | $1.8B | $3.4B | $2.4B | $4.2B | $4.3B | |
| Basic EPS (Cont. Ops) | $0.43 | $0.83 | $0.64 | $1.15 | $1.21 | |
| Diluted EPS (Cont. Ops) | $0.43 | $0.83 | $0.64 | $1.15 | $1.21 | |
| Weighted Average Basic Share | $12.1B | $12.1B | $11.4B | $10.8B | $10.6B | |
| Weighted Average Diluted Share | $12.1B | $12.2B | $11.4B | $10.8B | $10.6B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4B | $5.1B | $4.7B | $14.9B | $16.9B | |
| Revenue (Reported) | $7.1B | $8.7B | $7.2B | $9.6B | $9.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4B | $5.1B | $4.7B | $14.9B | $16.9B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $59.6B | $48.2B | $54.2B | $67.2B | $58.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $379.7M | $359.1M | $996.4M | $841.8M | $834.6M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $115.7B | $117.5B | $89.7B | $105.3B | $87.5B | |
| Property Plant And Equipment | $2.2B | $2.4B | $2B | $1.8B | $1.8B | |
| Long-Term Investments | $134.8B | $149.8B | $123.3B | $127.9B | $128.6B | |
| Goodwill | $2.2B | $2.4B | $2.2B | $2.4B | $2.5B | |
| Other Intangibles | $1.9B | $2.3B | $2B | $1.9B | $1.8B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $621.5B | $679.1B | $645.8B | $637.8B | $646.3B | |
| Accounts Payable | $169.1M | $183.3M | $157.4M | $484.7M | $277.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6.2B | $8.1B | $4.5B | $5.6B | $4.5B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $586.2B | $637.6B | $607.8B | $604.7B | $611.8B | |
| Common Stock | $4.5B | $5B | $4.6B | $4.3B | $4.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $35.3B | $41.5B | $37.9B | $33.1B | $34.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $44.8M | $11.1M | $10.2M | -- | -- | |
| Total Equity | $35.3B | $41.5B | $37.9B | $33.1B | $34.5B | |
| Total Liabilities and Equity | $621.5B | $679.1B | $645.8B | $637.8B | $646.3B | |
| Cash and Short Terms | $59.6B | $48.2B | $54.2B | $67.2B | $58.1B | |
| Total Debt | $229.4B | $224.4B | $208.1B | $204.1B | $211.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $74.8B | $90B | $72.1B | $66.1B | $59.5B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.2B | $896.6M | $827.6M | $962.2M | $1.4B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $130.2B | $126.5B | $118.6B | $101.2B | $85.7B | |
| Property Plant And Equipment | $2.2B | $2B | $1.6B | $1.7B | $1.8B | |
| Long-Term Investments | $149.5B | $134.9B | $127.4B | $137.7B | $145.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $674.8B | $712.8B | $614.2B | $645.5B | $689.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $219.5M | $577.6M | $257.5M | $636.2M | $482.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $636.6B | $670.3B | $583.7B | $613.4B | $654.5B | |
| Common Stock | $4.8B | $4.7B | $4B | $4.3B | $4.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $10.6M | $10.4M | -- | -- | -- | |
| Total Equity | $38.2B | $42.5B | $30.5B | $32.1B | $35.1B | |
| Total Liabilities and Equity | $674.8B | $712.8B | $614.2B | $645.5B | $689.6B | |
| Cash and Short Terms | $74.8B | $90B | $72.1B | $66.1B | $59.5B | |
| Total Debt | $220.8B | $229.3B | $192B | $207.8B | $218.8B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4B | $3.4B | $5.8B | $5B | $6.9B | |
| Depreciation & Amoritzation | $624.7M | $631.5M | $715.8M | $618M | $659.3M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$2.7B | -$1.5B | $20.8B | $23.2B | -$7B | |
| Capital Expenditures | $657.1M | $556.2M | $494.6M | $427.1M | $573.8M | |
| Cash Acquisitions | $426.5M | -$619M | $10.6M | -$287.9M | -$41.1M | |
| Cash From Investing | -$213.8M | -$1.2B | -$449.6M | -$663.3M | -$579.2M | |
| Dividends Paid (Ex Special Dividend) | -$3.1B | -- | -$3.8B | -$2.8B | -$3.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.6B | -- | $3.3B | -- | $541.3M | |
| Long-Term Debt Repaid | -$996.4M | -$2.8B | -$3.8B | -$990.3M | -$221.9M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$29.1M | -$30.8M | -$30.8M | -$27.4M | -$28.1M | |
| Cash From Financing | -$2.7B | -$3B | -$5.8B | -$6.9B | -$4.3B | |
| Beginning Cash (CF) | $51.5B | $47B | $42.8B | $51.3B | $68.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$5.6B | -$5.7B | $14.5B | $15.6B | -$11.9B | |
| Ending Cash (CF) | $46.1B | $41.3B | $57.5B | $66.3B | $55.6B | |
| Levered Free Cash Flow | -$3.3B | -$2.1B | $20.3B | $22.7B | -$7.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.3B | $1.4B | $1.2B | $1.9B | $1.9B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.2B | $28.6B | $345.8M | -$1.7B | $8.9B | |
| Capital Expenditures | $122.1M | $109.4M | $80.5M | $130.2M | $161.6M | |
| Cash Acquisitions | -$7M | -$1.4M | -$1.1M | $61.1K | -- | |
| Cash From Investing | -$129.1M | -$110.8M | -$81.6M | -$130.2M | -$161.6M | |
| Dividends Paid (Ex Special Dividend) | -- | $7.4M | $153.5M | $4.7M | -$74.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$515.2M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.8M | $679.2K | $1.5M | $42.9K | -$599.5K | |
| Cash From Financing | -$585.5M | -$70.7M | -$1.3B | -$563.4M | $713M | |
| Beginning Cash (CF) | $58.3B | $64.8B | $77B | $67.8B | $47.8B | |
| Foreign Exchange Rate Adjustment | -$536.1M | $513.1M | $733.9M | $515.1M | -$565.6M | |
| Additions / Reductions | $2.5B | $28.4B | -$997.6M | -$2.4B | $9.4B | |
| Ending Cash (CF) | $63B | $92.7B | $73.9B | $65.8B | $57.9B | |
| Levered Free Cash Flow | $3.1B | $28.5B | $265.3M | -$1.8B | $8.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.5B | $5.4B | $4.7B | $7.2B | $7.1B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22.7B | $31B | $320.6M | -$4.4B | -$4.9B | |
| Capital Expenditures | $613.1M | $499.3M | $425.3M | $562M | $585.6M | |
| Cash Acquisitions | $127.1M | -$604.9M | -$14.6M | -$310.1M | -$854.1K | |
| Cash From Investing | -$469.3M | -$1.1B | -$405.6M | -$820.4M | -$550.7M | |
| Dividends Paid (Ex Special Dividend) | -$21.1M | -$333.7M | -$6.1B | -$3.3B | -$3.5B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$31.8M | -$29.9M | -$26.3M | -$29.5M | -$28.4M | |
| Cash From Financing | -$2.3B | -$1.9B | -$11B | -$5.4B | -$2.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.9B | $28.1B | -$11.1B | -$10.6B | -$7.8B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $22.1B | $30.5B | -$104.7M | -$4.9B | -$5.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $4.3B | $3.2B | $5.4B | $5.6B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $18.1B | $50.7B | $30.2B | $2.6B | $4.8B | |
| Capital Expenditures | $394.1M | $337.2M | $268M | $402.9M | $414.6M | |
| Cash Acquisitions | -$7M | $7.1M | -$18.1M | -$40.3M | -- | |
| Cash From Investing | -$401.1M | -$330.1M | -$286.1M | -$443.1M | -$414.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -$333.7M | -$2.7B | -$3.1B | -$3.5B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$515.2M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$31.6M | -$30.7M | -$26.2M | -$28.3M | -$28.6M | |
| Cash From Financing | -$2.2B | -$997.5M | -$6.1B | -$4.6B | -$2.6B | |
| Beginning Cash (CF) | $157B | $178.4B | $212.6B | $204.3B | $151.7B | |
| Foreign Exchange Rate Adjustment | -$639.7M | $721.6M | $1.2B | -$272.2M | -$324.4M | |
| Additions / Reductions | $15.5B | $49.3B | $23.8B | -$2.4B | $1.7B | |
| Ending Cash (CF) | $174.6B | $227.5B | $232B | $202.6B | $153.8B | |
| Levered Free Cash Flow | $17.7B | $50.3B | $29.9B | $2.2B | $4.3B | |
Get NRDBY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NRDBY
Sector
P/E ratio
6.92x
11.99x
PEG ratio
3.17x
0.36x
P/B ratio
1.06x
1.05x
Price / LTM sales
2.88x
2.55x
Growth Metrics
NRDBY
Sector
Revenue growth
3.17%
6.08%
Earnings growth
-4.3%
6.45%
Revenue (5-year growth)
4.45%
5.85%
Earnings forecast
$0.38
$0.56
Profitability
NRDBY
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
2.24%
5.27%
Return on assets
0.83%
0.98%
Return on equity
16.51%
9.43%
Earnings Date
Last Earnings Date
Oct
17
Next Earnings Date
Jan
30
Estimated Next Earnings Date
Jan
16
Balance Sheet
NRDBY
Sector
Total cash
$59.5B
$615.3M
Short term investments
--
$408.4M
Total assets
$646.3B
$4.5B
Long term debt
$218.8B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
